BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Athithan L, Gulsin GS, McCann GP, Levelt E. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date. World J Diabetes 2019; 10(10): 490-510 [PMID: 31641426 DOI: 10.4239/wjd.v10.i10.490]
URL: https://www.wjgnet.com/1948-9358/full/v10/i10/490.htm
Number Citing Articles
1
Ingrid M. Heyns, Garrett Davis, Raghu Ganugula, M. N. V. Ravi Kumar, Meenakshi Arora. Glucose-Responsive Microgel Comprising Conventional Insulin and Curcumin-Laden Nanoparticles: a Potential Combination for Diabetes ManagementThe AAPS Journal 2023; 25(4) doi: 10.1208/s12248-023-00839-w
2
Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella, Isabella Leo. Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonanceCardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02181-7
3
Joanna M. Bilak, Jian L. Yeo, Gaurav S. Gulsin, Anna-Marie Marsh, Manjit Sian, Abhishek Dattani, Sarah L. Ayton, Kelly S. Parke, Moira Bain, Wenjie Pang, Sherif Boulos, Tim G. St Pierre, Melanie J. Davies, Thomas Yates, Gerry P. McCann, Emer M. Brady. Impact of the Remission of Type 2 Diabetes on Cardiovascular Structure and Function, Exercise Capacity and Risk Profile: A Propensity Matched AnalysisJournal of Cardiovascular Development and Disease 2023; 10(5): 191 doi: 10.3390/jcdd10050191
4
Xiao‐long Zhang, Gang Zhang, Ze‐hong Bai. miR‐34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin‐1Cell Biology International 2021; 45(3): 642 doi: 10.1002/cbin.11512
5
Ioan‐Alexandru Minciună, Olga Hilda Orășan, Iulia Minciună, Andrada‐Luciana Lazar, Adela Viviana Sitar‐Tăut, Monica Oltean, Raluca Tomoaia, Mihai Puiu, Dan‐Andrei Sitar‐Tăut, Dana Pop, Angela Cozma. Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imagingEuropean Journal of Clinical Investigation 2021; 51(4) doi: 10.1111/eci.13475
6
Zhaohui Jiang, Lingyun Fu, Yini Xu, Xiaoxia Hu, Hong Yang, Yanyan Zhang, Hong Luo, Shiquan Gan, Ling Tao, Guiyou Liang, Xiangchun Shen. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responsesScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-63498-3
7
Lin Wang, Yin Cai, Liguo Jian, Chi Wai Cheung, Liangqing Zhang, Zhengyuan Xia. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathyCardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-020-01188-0
8
Lorena Ciumărnean, Mircea Vasile Milaciu, Vasile Negrean, Olga Hilda Orășan, Stefan Cristian Vesa, Octavia Sălăgean, Silvina Iluţ, Sonia Irina Vlaicu. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the ElderlyInternational Journal of Environmental Research and Public Health 2021; 19(1): 207 doi: 10.3390/ijerph19010207
9
Barry A Borlaug, Michael D Jensen, Dalane W Kitzman, Carolyn S P Lam, Masaru Obokata, Oliver J Rider. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targetsCardiovascular Research 2023; 118(18): 3434 doi: 10.1093/cvr/cvac120
10
J. A. Henry, I. Abdesselam, O. Deal, A. J. Lewis, J. Rayner, M. Bernard, A. Dutour, B. Gaborit, F. Kober, A. Soghomonian, B. Sgromo, J. Byrne, T. Bege, B. A. Borlaug, S. Neubauer, O. J. Rider. The effect of bariatric surgery type on cardiac reverse remodellingInternational Journal of Obesity 2024; 48(6): 808 doi: 10.1038/s41366-024-01474-x
11
Xiu Wang, Shi Jin, Weina Hu, Gaetano Santulli. A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman PrimatesJournal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/9676754
12
Bhoomika Sherkhane, Gundu Chayanika, Anika Sood, Dharmendra Kumar Khatri, Shashi Bala Singh. Mitochondrial remodelling—a vicious cycle in diabetic complicationsMolecular Biology Reports 2021; 48(5): 4721 doi: 10.1007/s11033-021-06408-8
13
Anastasia Nikolaidou, Ioannis Ventoulis, Georgios Karakoulidis, Vasileios Anastasiou, Stylianos Daios, Spyridon-Filippos Papadopoulos, Matthaios Didagelos, John Parissis, Theodoros Karamitsos, Kalliopi Kotsa, Antonios Ziakas, Vasileios Kamperidis. Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative ReviewMedicina 2024; 60(6): 912 doi: 10.3390/medicina60060912
14
Yuxin Li, Zhang Zhang, Sen Li, Tingting Yu, Zhaoqi Jia. Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium SignalingFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.682273
15
Lamiaa A. Ahmed, Nesma A. Shiha, Amina S. Attia. Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling CascadesFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579206
16
Priyanka Mathur, Vibha Rani. Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeuticsMolecular and Cellular Biochemistry 2023; 478(2): 229 doi: 10.1007/s11010-022-04473-6
17
Vera S. Ivanchenko, Alina A. Gagarina, Irina Ya. Goryanskaya, Olga V. Soldatova, Alexey V. Ushakov. PATHOGENIC MECHANISMS OF HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUSComplex Issues of Cardiovascular Diseases 2023; 12(4S): 162 doi: 10.17802/2306-1278-2023-12-4S-162-172
18
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, Weronika Frąk, Piotr Fularski, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Diabetic Cardiomyopathy—From Basics through Diagnosis to TreatmentBiomedicines 2024; 12(4): 765 doi: 10.3390/biomedicines12040765
19
Byoung-Geun Han, Jun Young Lee, Mi Ryung Kim, Hanwul Shin, Jae-Seok Kim, Jae-Won Yang, Jong Yeon Kim, Vincenzo Lionetti. Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysisPLOS ONE 2020; 15(7): e0235640 doi: 10.1371/journal.pone.0235640
20
珏 王. Advances in the Pathogenesis and Treatment of MCP-1 in Diabetic ComplicationsAdvances in Clinical Medicine 2022; 12(11): 10856 doi: 10.12677/ACM.2022.12111563
21
Yu-Rui Jiao, Kai-Xuan Chen, Xiang Tang, Yu-Long Tang, Hai-Lin Yang, Yu-Long Yin, Chang-Jun Li. Exosomes derived from mesenchymal stem cells in diabetes and diabetic complicationsCell Death & Disease 2024; 15(4) doi: 10.1038/s41419-024-06659-w
22
James L. Januzzi, Javed Butler, Stefano Del Prato, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Gregory D. Lewis, Thomas H. Marwick, Julio Rosenstock, W.H. Wilson Tang, Faiez Zannad, Francesca Lawson, Riccardo Perfetti, Alessia Urbinati. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathyAmerican Heart Journal 2023; 256: 25 doi: 10.1016/j.ahj.2022.11.003
23
Honglin Wang, Eric Zi Rui Wang, Biao Feng, Subrata Chakrabarti, Filomena de Nigris. CircRNA_012164/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathyPLOS ONE 2024; 19(7): e0302772 doi: 10.1371/journal.pone.0302772
24
Sabine Kleissl-Muir, Bodil Rasmussen, Alice Owen, Caryn Zinn, Andrea Driscoll. Low Carbohydrate Diets for Diabetic Cardiomyopathy: A HypothesisFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.865489
25
Xiaopan Chen, Chuan Yun, Hailong Zheng, Xu Chen, Qianfei Han, Hua Pan, Yang Wang, Jianghua Zhong. The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunctionBioengineered 2021; 12(1): 5491 doi: 10.1080/21655979.2021.1964894
26
Lama A. Ammar, Mohamad I. Nahlawi, Nizar W. Shayya, Hilda E. Ghadieh, Nadim S. Azar, Frédéric Harb, Assaad A. Eid. Immunomodulatory Approaches in Diabetes-Induced Cardiorenal SyndromesFrontiers in Cardiovascular Medicine 2021; 7 doi: 10.3389/fcvm.2020.630917
27
Sabine Kleissl-Muir, Caryn Zinn, Bodil Rasmussen, Alice Owen, Andrea Driscoll. Low carbohydrate diet for diabetic cardiomyopathy: Protocol for a randomised controlled trialJournal of Metabolic Health 2022; 5(1) doi: 10.4102/jir.v5i1.73
28
Joanna M. Bilak, Gaurav S. Gulsin, Gerry P. McCann. Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitusTherapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/2042018820980235
29
Chidhambara Priya Dharshini Kottaisamy, Divya S. Raj, V. Prasanth Kumar, Umamaheswari Sankaran. Experimental animal models for diabetes and its related complications—a reviewLaboratory Animal Research 2021; 37(1) doi: 10.1186/s42826-021-00101-4
30
Leila Chodari, Sina Fatehfar, Mahan Ahmadi, Vajihe Ghorbanzadeh. The impact of diabetes on tight junctions in cardiomyopathy dysfunctionJournal of Diabetes & Metabolic Disorders 2024;  doi: 10.1007/s40200-024-01469-5
31
Alexander E. Berezin, Alexander A. Berezin. Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative ReviewDiabetes Therapy 2020; 11(6): 1271 doi: 10.1007/s13300-020-00835-9
32
Ressin Varghese, C. George Priya Doss, Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam, Thomas Efferth, Siva Ramamoorthy. Cardioprotective effects of phytopigments via multiple signaling pathwaysPhytomedicine 2022; 95: 153859 doi: 10.1016/j.phymed.2021.153859
33
J. A. Henry, I. Abdesselam, O. Deal, A. J. Lewis, J. Rayner, M. Bernard, A. Dutour, B. Gaborit, F. Kober, A. Soghomonian, B. Sgromo, J. Byrne, T. Bege, S. Neubauer, B. A. Borlaug, O. J. Rider. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometryFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1092777
34
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan. Diabetic heart disease: A clinical updateWorld Journal of Diabetes 2021; 12(4): 383-406 doi: 10.4239/wjd.v12.i4.383
35
Raúl Vivar, Renatto Anfossi, Claudio Humeres, Mabel Catalán, Christopher Reyes, Simone Cárdenas, Alejandra Contreras, Pablo Aránguiz, Fabiola González, Guillermo Diaz-Araya. FoxO1 is required for high glucose-dependent cardiac fibroblasts into myofibroblast phenoconversionCellular Signalling 2021; 83: 109978 doi: 10.1016/j.cellsig.2021.109978
36
Elia Smeir, Ulrich Kintscher, Anna Foryst-Ludwig. Adipose tissue–heart crosstalk as a novel target for treatment of cardiometabolic diseasesCurrent Opinion in Pharmacology 2021; 60: 249 doi: 10.1016/j.coph.2021.07.017
37
Omonzejie E. Imaralu, Chandrakala Aluganti Narasimhulu, Pawan K. Singal, Dinender K. Singla. Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complicationsCanadian Journal of Physiology and Pharmacology 2024; 102(01): 14 doi: 10.1139/cjpp-2023-0223
38
Xiao-fei Geng, Wen-yu Shang, Zhong-wen Qi, Chi Zhang, Wen-xiu Li, Zhi-peng Yan, Xin-biao Fan, Jun-ping Zhang. The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosisJournal of Diabetes and its Complications 2024; 38(10): 108848 doi: 10.1016/j.jdiacomp.2024.108848
39
Eric Wang, Shali Chen, Honglin Wang, Tori Chen, Subrata Chakrabarti. Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylationCardiovascular Diabetology 2023; 22(1) doi: 10.1186/s12933-023-02039-4
40
Shu Song, Yue Ding, Guo-liang Dai, Yue Zhang, Meng-ting Xu, Jie-ru Shen, Ting-ting Chen, Yun Chen, Guo-liang Meng. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activationActa Pharmacologica Sinica 2021; 42(2): 230 doi: 10.1038/s41401-020-0490-7
41
Setareh Soltani, Kamran Mansouri, Shahram Parvaneh, Avnesh S. Thakor, Flemming Pociot, Reza Yarani. Diabetes complications and extracellular vesicle therapyReviews in Endocrine and Metabolic Disorders 2022; 23(3): 357 doi: 10.1007/s11154-021-09680-y
42
Pengbo Sun, Yangyang Wang, Yipei Ding, Jingyi Luo, Jin Zhong, Naihan Xu, Yaou Zhang, Weidong Xie. Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathwayiScience 2021; 24(6): 102521 doi: 10.1016/j.isci.2021.102521
43
Ahmed Diab, Carla Valenzuela Ripoll, Zhen Guo, Ali Javaheri. HDL Composition, Heart Failure, and Its ComorbiditiesFrontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.846990
44
Sabine Kleissl-Muir, Alice Owen, Bodil Rasmussen, Caryn Zinn, Andrea Driscoll. Effects of a low carbohydrate diet on heart failure symptoms and quality of life in patients with diabetic cardiomyopathy: A randomised controlled trial pilot studyNutrition, Metabolism and Cardiovascular Diseases 2023; 33(12): 2455 doi: 10.1016/j.numecd.2023.08.015
45
Eva R. Meulendijks, Carolina Janssen-Telders, Elise L. Hulsman, Nick Lobe, Pietro Zappala, Marc M. Terpstra, Robin Wesselink, Tim A.C. de Vries, Rushd F. Al-Shama, Ruben N. van Veen, Steve M.M. de Castro, Claire E.E. de Vries, Leontien M.G. Nijland, R. Nils Planken, Sebastien P.J. Krul, Joris R. de Groot. The change of epicardial adipose tissue characteristics and vulnerability for atrial fibrillation upon drastic weight lossAdipocyte 2024; 13(1) doi: 10.1080/21623945.2024.2395565
46
Huan Chen, Da Tran, Hsiu-Chiung Yang, Sven Nylander, Yochai Birnbaum, Yumei Ye. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR InterplayCardiovascular Drugs and Therapy 2020; 34(4): 443 doi: 10.1007/s10557-020-06978-y
47
Ramzi Ahmad Al-Horani, Saja Janaydeh, Bahaa Al-Trad, Mukhallad Mohammed Aljanabi, Riyadh Muhaidat. Acute Exercise Promptly Normalizes Myocardial Myosin Heavy-Chain Isoform mRNA Composition in Diabetic Rats: Implications for Diabetic CardiomyopathyMedicina 2023; 59(12): 2193 doi: 10.3390/medicina59122193
48
Yumei Ye, Yochai Birnbaum, Steven G. Widen, Zhaohui Zhang, Shipeng Zhu, Mandeep Bajaj, Huan Chen. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic CardiomyopathyCardiovascular Drugs and Therapy 2020; 34(6): 835 doi: 10.1007/s10557-020-07043-4
49
Joanna M Bilak, Uazman Alam, Christopher A Miller, Gerry P McCann, Jayanth R Arnold, Prathap Kanagala. Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and PrognosisCardiac Failure Review 2022; 8 doi: 10.15420/cfr.2022.12
50
Idowu Sunday Oyeleye, Olajide Raymond Ojo, Adeyinka Samuel Ajeigbe, Ganiyu Oboh. Hesperidin and acarbose combination therapy modulates inflammatory cytokines and cardiomyopathy-related biomolecules in diabetic rats subjected to aerobic exerciseComparative Clinical Pathology 2024;  doi: 10.1007/s00580-024-03611-4
51
Prabhnain Kaur, Ritu Dahiya, Mukesh Nandave, Kalicharan Sharma, Ramesh K. Goyal. Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complicationsCell Biochemistry and Function 2024; 42(4) doi: 10.1002/cbf.4037
52
Dariga Uaydinichna Akasheva, Tatyana Gennadyevna Utina, Olga Nikolaevna Dzhioeva, Oxana Mikhailovna Drapkina. Subclinical Left Ventricular Dysfunction over Seven-Year Follow-Up in Type 2 Diabetes Patients without Cardiovascular DiseasesBiomedicines 2024; 12(9): 2031 doi: 10.3390/biomedicines12092031
53
Emma McAlister, Melissa Kirkby, Juan Domínguez-Robles, Alejandro J. Paredes, Qonita Kurnia Anjani, Kurtis Moffatt, Lalitkumar K. Vora, Aaron R.J. Hutton, Peter E. McKenna, Eneko Larrañeta, Ryan F. Donnelly. The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosisAdvanced Drug Delivery Reviews 2021; 175: 113825 doi: 10.1016/j.addr.2021.06.002
54
Hui‐Min Zhou, Yun Ti, Hui Wang, Yuan‐Yuan Shang, Ya‐Peng Liu, Xiao‐Ning Ni, Di Wang, Zhi‐Hao Wang, Wei Zhang, Ming Zhong. Cell death‐inducing DFFA‐like effector C/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylationThe FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002562R
55
Ernest A. Adeghate, Sahar Mohsin, Ahmed Bin Amar, Suhail AlAmry, Mariam AlOtaiba, Omobola Awosika Oyeleye, Jaipaul Singh. Etiology, Prevention and Management of CardiomyopathyCardiology and Cardiovascular Medicine 2024; 6 doi: 10.5772/intechopen.1006679
56
Grace W. M. Walters, Emma Redman, Gaurav S. Gulsin, Joseph Henson, Stavroula Argyridou, Thomas Yates, Melanie J. Davies, Kelly Parke, Gerry P. McCann, Emer M. Brady. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetesJournal of Nutritional Science 2021; 10 doi: 10.1017/jns.2021.82
57
Edgar Francisco Carrizales-Sepúlveda, Raymundo Vera-Pineda, Raúl Alberto Jiménez-Castillo, Jorge Rafael Violante-Cumpa, Ramiro Flores-Ramírez, Alejandro Ordaz-Farías. The Heart in Diabetic Ketoacidosis: A Narrative Review Focusing on the Acute Cardiac Effects and Electrocardiographic AbnormalitiesThe American Journal of the Medical Sciences 2021; 361(6): 690 doi: 10.1016/j.amjms.2020.11.030
58
Xu Zhang, Pei-Xiong Ke, Xun Yuan, Gui-Ping Zhang, Wen-Liang Chen, Gen-Shui Zhang, Juan Carlos Corona. Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in MiceBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8881843
59
Paolo Severino, Andrea D'Amato, Mariateresa Pucci, Fabio Infusino, Francesco Adamo, Lucia Ilaria Birtolo, Lucrezia Netti, Giulio Montefusco, Cristina Chimenti, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, William M. Chilian, Francesco Fedele. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular DysfunctionInternational Journal of Molecular Sciences 2020; 21(21): 8118 doi: 10.3390/ijms21218118